NET PROFIT (x1000 EUR)
EMPLOYEES
Bioadvice A/S
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
10
|
-157
|
32 |
| Total assets |
21,825
|
20,714
|
18,259 |
| Current assets |
1,169
|
372
|
2,866 |
| Current liabilities |
9,142
|
17,047
|
14,343 |
| Equity capital |
12,026
|
3,049
|
3,178 |
| - share capital |
67
|
67
|
67 |
| Employees (average) |
35
|
35
|
35 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
55.1%
|
14.7%
|
17.4% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
12.8%
|
2.2%
|
20.0% |
| Return on equity (ROE) |
0.1%
|
-5.1%
|
1.0% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.